@prefix ns1: <http://example.org/relation/> .
@prefix ns2: <http://example.org/> .

<http://example.org/doc/samplepdf> a ns2:Document ;
    ns2:contains <http://example.org/entity/001_Value_for_EFS>,
        <http://example.org/entity/008_Value_for_OS>,
        <http://example.org/entity/238_Statistic_for_EFS>,
        <http://example.org/entity/251_Statistic_for_OS>,
        <http://example.org/entity/60_month_EFS_500_ml_Data>,
        <http://example.org/entity/60_month_EFS_AVD_500_ml_data_point>,
        <http://example.org/entity/60_month_EFS_AV_2_500_ml_data_point>,
        <http://example.org/entity/60_month_OS_500_ml_Data>,
        <http://example.org/entity/60_month_OS_AVD_500_ml_data_point>,
        <http://example.org/entity/60_month_OS_AV_2_500_ml_data_point>,
        <http://example.org/entity/800_Statistic>,
        <http://example.org/entity/903_Statistic>,
        <http://example.org/entity/931_Statistic>,
        <http://example.org/entity/95_Cl_705_908_Confidence_Interval>,
        <http://example.org/entity/95_Cl_868_999_Confidence_Interval>,
        <http://example.org/entity/95_Cl_871_935_Confidence_Interval>,
        <http://example.org/entity/95_Cl_946_988_Confidence_Interval>,
        <http://example.org/entity/967_Statistic>,
        <http://example.org/entity/AREN0533_Study>,
        <http://example.org/entity/AVD150_treatment>,
        <http://example.org/entity/AVD250_treatment>,
        <http://example.org/entity/Adult_Wilms_tumor_Condition>,
        <http://example.org/entity/Ann_Surg_Journal>,
        <http://example.org/entity/Anne_M_Smets_author>,
        <http://example.org/entity/Arnauld_C_Verschuur_author>,
        <http://example.org/entity/Aronson_D_C_Author>,
        <http://example.org/entity/Austria_Country>,
        <http://example.org/entity/Beatriz_de_Camargo_author>,
        <http://example.org/entity/Bilateral_disease_stage_V_condition_stage>,
        <http://example.org/entity/Bone_Marrow_Transplant_Journal>,
        <http://example.org/entity/Breslow_N_E_Author>,
        <http://example.org/entity/Brok_J_Author>,
        <http://example.org/entity/CCSK_medical_condition>,
        <http://example.org/entity/CDCV_treatment>,
        <http://example.org/entity/CMN_medical_condition>,
        <http://example.org/entity/COGNWTS_study>,
        <http://example.org/entity/COG_protocol_Protocol>,
        <http://example.org/entity/CT_diagnostic_procedure>,
        <http://example.org/entity/CT_only_nodules_Medical_Term>,
        <http://example.org/entity/Childrens_Oncology_Group_AREN0321_Study>,
        <http://example.org/entity/Childrens_Oncology_Group_COG_organization>,
        <http://example.org/entity/Childrens_Oncology_Group_study_AREN0533_Study>,
        <http://example.org/entity/Christian_R%C3%BCbe_author>,
        <http://example.org/entity/Christophe_Bergeron_author>,
        <http://example.org/entity/Davila_Fajardo_author>,
        <http://example.org/entity/Daw_N_C_Author>,
        <http://example.org/entity/Dome_J_S_Author>,
        <http://example.org/entity/ESRD_condition>,
        <http://example.org/entity/Enucleation_Surgical_Technique>,
        <http://example.org/entity/Eur_J_Cancer_Journal>,
        <http://example.org/entity/Europe_Region>,
        <http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_Project>,
        <http://example.org/entity/ExPO_r_Net_Platform>,
        <http://example.org/entity/Expert_Rev_Anticancer_Ther_Journal>,
        <http://example.org/entity/Filippo_Spreafico_author>,
        <http://example.org/entity/Four_drug_regimen_treatment>,
        <http://example.org/entity/France_Country>,
        <http://example.org/entity/Furtwangler_R_Author>,
        <http://example.org/entity/GPOH_Organization>,
        <http://example.org/entity/Geert_O_Janssens_author>,
        <http://example.org/entity/Gema_L_Ram%C3%ADrez_Villar_author>,
        <http://example.org/entity/Germany_Country>,
        <http://example.org/entity/Gordan_M_Vujanic_author>,
        <http://example.org/entity/Great_Ormond_Street_Institute_of_Child_Health_institution>,
        <http://example.org/entity/Green_D_M_Author>,
        <http://example.org/entity/Group_AA_patient_group>,
        <http://example.org/entity/Group_BB_patient_group>,
        <http://example.org/entity/Group_CC_patient_group>,
        <http://example.org/entity/Grundy_P_Author>,
        <http://example.org/entity/HR_1_treatment_regimen>,
        <http://example.org/entity/HR_Metric>,
        <http://example.org/entity/Ha_T_C_Author>,
        <http://example.org/entity/Hale_J_Author>,
        <http://example.org/entity/Hamilton_T_E_Author>,
        <http://example.org/entity/Harm_van_Tinteren_author>,
        <http://example.org/entity/Heidi_Segers_author>,
        <http://example.org/entity/High_risk_disease_risk_category>,
        <http://example.org/entity/Hospital_Universitario_Virgen_del_Roc%C3%ADo_institution>,
        <http://example.org/entity/Iceland_Country>,
        <http://example.org/entity/Indolfi_P_Author>,
        <http://example.org/entity/Infant_Wilms_tumours_Disease>,
        <http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_organization>,
        <http://example.org/entity/Instituto_Nacional_de_Cancer_INCA_institution>,
        <http://example.org/entity/Intermediate_risk_disease_risk_category>,
        <http://example.org/entity/International_Society_of_Paediatric_Oncology_Renal_Tumour_Study_Group_SIOPRTSG_organization>,
        <http://example.org/entity/International_collaboration_Concept>,
        <http://example.org/entity/Italy_Country>,
        <http://example.org/entity/Ivo_Leuschner_author>,
        <http://example.org/entity/J_Clin_Oncol_Journal>,
        <http://example.org/entity/J_Pediatr_Hematol_Oncol_Journal>,
        <http://example.org/entity/J_Urol_Journal>,
        <http://example.org/entity/Jan_Godzinski_author>,
        <http://example.org/entity/Janna_A_Hol_author>,
        <http://example.org/entity/Jesper_Brok_author>,
        <http://example.org/entity/Kaplan_Meier_analysis_analysis_method>,
        <http://example.org/entity/Kathy_Pritchard_Jones_author>,
        <http://example.org/entity/Klin_Padiatr_Journal>,
        <http://example.org/entity/Kremens_B_Author>,
        <http://example.org/entity/LogRank_P_Statistic_Type>,
        <http://example.org/entity/Low_risk_disease_risk_category>,
        <http://example.org/entity/MRTK_medical_condition>,
        <http://example.org/entity/Manfred_Gessler_author>,
        <http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_author>,
        <http://example.org/entity/Metzger_M_L_Journal_Author>,
        <http://example.org/entity/NSS_Surgical_Technique>,
        <http://example.org/entity/NSS_surgery_type>,
        <http://example.org/entity/NWTS_4_Study>,
        <http://example.org/entity/NWTS_5_Study>,
        <http://example.org/entity/NWTS_5_relapse_protocol_study>,
        <http://example.org/entity/National_Wilms_Tumor_Study_Group_Organization>,
        <http://example.org/entity/Netherlands_Cancer_Institute_institution>,
        <http://example.org/entity/Netherlands_Country>,
        <http://example.org/entity/Norbert_Graf_author>,
        <http://example.org/entity/Paola_Collini_author>,
        <http://example.org/entity/Partial_Nephrectomy_Surgical_Technique>,
        <http://example.org/entity/Pediatr_Blood_Cancer_Journal>,
        <http://example.org/entity/Poland_Country>,
        <http://example.org/entity/Princess_M%C3%A1xima_Center_for_Paediatric_Oncology_institution>,
        <http://example.org/entity/RCC_medical_condition>,
        <http://example.org/entity/Relapsed_group_CC_patient_group>,
        <http://example.org/entity/Rhoikos_Furtw%C3%A4ngler_author>,
        <http://example.org/entity/SIOP2001_Study>,
        <http://example.org/entity/SIOP2001_protocol_protocol>,
        <http://example.org/entity/SIOP2001_randomized_trial_clinical_trial>,
        <http://example.org/entity/SIOP2001_study>,
        <http://example.org/entity/SIOP9301_trial_trial>,
        <http://example.org/entity/SIOPRTSG_Organization>,
        <http://example.org/entity/SIOPRTSG_organization>,
        <http://example.org/entity/SIOPRTSG_panel_Organization>,
        <http://example.org/entity/SIOP_2001_trial_trial>,
        <http://example.org/entity/SIOP_9GPOH_Trial>,
        <http://example.org/entity/SIOP_Organization>,
        <http://example.org/entity/SIOP_renal_tumour_protocol_Protocol>,
        <http://example.org/entity/Segers_H_Author>,
        <http://example.org/entity/Spain_Country>,
        <http://example.org/entity/Spreafico_F_Author>,
        <http://example.org/entity/Sudour_H_Author>,
        <http://example.org/entity/Terenziani_M_Author>,
        <http://example.org/entity/Tournade_M_F_Author>,
        <http://example.org/entity/UKW3_trial_clinical_trial>,
        <http://example.org/entity/UKW_R_protocol_study>,
        <http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_organization>,
        <http://example.org/entity/UK_Country>,
        <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_protocol>,
        <http://example.org/entity/UMBRELLA_protocol_Project>,
        <http://example.org/entity/UMBRELLA_protocol_Protocol>,
        <http://example.org/entity/UMBRELLA_protocol_guideline>,
        <http://example.org/entity/UMBRELLA_protocol_protocol>,
        <http://example.org/entity/UMBRELLA_protocol_treatment_protocol>,
        <http://example.org/entity/UMRELLA_SIOP_RTSG_2016_protocol_protocol>,
        <http://example.org/entity/University_Hospital_of_Wales_institution>,
        <http://example.org/entity/Weirich_A_Author>,
        <http://example.org/entity/Wilms_tumor_Condition>,
        <http://example.org/entity/Wilms_tumour_Disease>,
        <http://example.org/entity/Wilms_tumour_cancer_type>,
        <http://example.org/entity/Wilms_tumour_condition>,
        <http://example.org/entity/Wilms_tumour_disease>,
        <http://example.org/entity/Wilms_tumour_medical_condition>,
        <http://example.org/entity/Wilms_tumour_treatment_Medical_treatment>,
        <http://example.org/entity/Wilms_tumours_disease>,
        <http://example.org/entity/Wilms_tumours_medical_condition>,
        <http://example.org/entity/actinomycin_D_Medication>,
        <http://example.org/entity/actinomycin_D_drug>,
        <http://example.org/entity/adult_patients_Patient_Group>,
        <http://example.org/entity/autologous_stem_cell_rescue_ASCR_treatment>,
        <http://example.org/entity/blastemal_type_Wilms_tumour_medical_condition>,
        <http://example.org/entity/blastemal_type_Wilms_tumours_subtype>,
        <http://example.org/entity/blastemal_type_tumours_disease_attribute>,
        <http://example.org/entity/blastemal_type_tumours_medical_condition>,
        <http://example.org/entity/camptothecins_irinotecan_or_topotecan_medical_substance>,
        <http://example.org/entity/carboplatin_Medication>,
        <http://example.org/entity/carboplatin_drug>,
        <http://example.org/entity/carboplatin_medical_substance>,
        <http://example.org/entity/chemotherapy_Treatment>,
        <http://example.org/entity/chemotherapy_treatment>,
        <http://example.org/entity/chest_CT_diagnostic_tool>,
        <http://example.org/entity/childhood_renal_tumours_disease>,
        <http://example.org/entity/clear_cell_sarcoma_of_the_kidney_disease>,
        <http://example.org/entity/congenital_mesoblastic_nephroma_Disease>,
        <http://example.org/entity/congenital_mesoblastic_nephroma_disease>,
        <http://example.org/entity/cumulative_doxorubicin_dose_of_300_mgm2_Dosage>,
        <http://example.org/entity/cyclophosphamide_Medication>,
        <http://example.org/entity/cyclophosphamide_drug>,
        <http://example.org/entity/cyclophosphamide_medical_substance>,
        <http://example.org/entity/diffuse_anaplasia_disease_attribute>,
        <http://example.org/entity/diffuse_anaplasia_medical_condition>,
        <http://example.org/entity/dose_of_150_mgm2_Dosage>,
        <http://example.org/entity/doxorubicin_Medication>,
        <http://example.org/entity/doxorubicin_drug>,
        <http://example.org/entity/epithelial_tumour_types_medical_condition>,
        <http://example.org/entity/etoposide_Medication>,
        <http://example.org/entity/etoposide_drug>,
        <http://example.org/entity/etoposide_medical_substance>,
        <http://example.org/entity/event_free_survival_EFS_outcome_measure>,
        <http://example.org/entity/flank_irradiation_treatment>,
        <http://example.org/entity/focal_anaplasia_type_tumours_medical_condition>,
        <http://example.org/entity/high_risk_risk_level>,
        <http://example.org/entity/ifosfamide_medical_substance>,
        <http://example.org/entity/intermediate_risk_risk_level>,
        <http://example.org/entity/large_volume_tumours_medical_condition>,
        <http://example.org/entity/low_risk_risk_level>,
        <http://example.org/entity/lung_or_metastasis_radiotherapy_treatment>,
        <http://example.org/entity/malignant_rhabdoid_tumour_of_the_kidney_disease>,
        <http://example.org/entity/malignant_rhabdoid_tumours_Disease>,
        <http://example.org/entity/metastatic_disease_medical_condition>,
        <http://example.org/entity/minimally_invasive_or_laparoscopic_surgery_surgery_type>,
        <http://example.org/entity/mixed_tumours_medical_condition>,
        <http://example.org/entity/nephrectomy_Treatment>,
        <http://example.org/entity/non_Wilms_tumours_disease_category>,
        <http://example.org/entity/overall_survival_outcome_measure>,
        <http://example.org/entity/proton_therapy_treatment>,
        <http://example.org/entity/pulmonary_metastases_medical_condition>,
        <http://example.org/entity/pulmonary_radiotherapy_treatment>,
        <http://example.org/entity/radiotherapy_Treatment>,
        <http://example.org/entity/radiotherapy_treatment>,
        <http://example.org/entity/renal_cell_carcinoma_disease>,
        <http://example.org/entity/renal_tumour_patients_population>,
        <http://example.org/entity/stage_IIIII_regressive_tumours_medical_condition>,
        <http://example.org/entity/stage_IV_WT_cancer_stage>,
        <http://example.org/entity/stage_IV_disease_medical_condition>,
        <http://example.org/entity/stromal_tumour_types_medical_condition>,
        <http://example.org/entity/surgery_Treatment>,
        <http://example.org/entity/surgery_treatment>,
        <http://example.org/entity/van_den_Heuvel_Eibrink_M_M_Author>,
        <http://example.org/entity/vincristine_Medication>,
        <http://example.org/entity/vincristine_and_actinomycin_D_Treatment>,
        <http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_Treatment>,
        <http://example.org/entity/vincristine_and_irinotecan_Treatment>,
        <http://example.org/entity/vincristine_drug>,
        <http://example.org/entity/whole_lung_irradiation_treatment>,
        <http://example.org/entity/wwwsiop_rtsgeu_website> .

<http://example.org/entity/60_month_EFS_500_ml_entity> ns1:has_value <http://example.org/entity/800_entity>,
        <http://example.org/entity/903_entity> .

<http://example.org/entity/60_month_OS_500_ml_entity> ns1:has_value <http://example.org/entity/931_entity>,
        <http://example.org/entity/967_entity> .

<http://example.org/entity/AVD150_entity> ns1:is_treatment_for <http://example.org/entity/stage_IV_WT_entity> .

<http://example.org/entity/AVD250_entity> ns1:is_treatment_for <http://example.org/entity/stage_IV_WT_entity> .

<http://example.org/entity/Aronson_D_C_entity> ns1:Published_in <http://example.org/entity/Pediatr_Blood_Cancer_entity> .

<http://example.org/entity/Austria_entity> ns1:location_of <http://example.org/entity/St_Anna_KinderspitalCCRI_Vienna_entity> .

<http://example.org/entity/Breslow_N_E_entity> ns1:Published_in <http://example.org/entity/J_Urol_entity> .

<http://example.org/entity/Brok_J_entity> ns1:Published_in <http://example.org/entity/Eur_J_Cancer_entity> .

<http://example.org/entity/CDCV_entity> ns1:is_treatment_for <http://example.org/entity/stage_IV_WT_entity> .

<http://example.org/entity/Comparing_entity> ns1:shows <http://example.org/entity/NWTS_4_entity>,
        <http://example.org/entity/NWTS_5_entity> .

<http://example.org/entity/Davila_Fajardo_entity> ns1:analysis_by <http://example.org/entity/SIOP2001_entity> .

<http://example.org/entity/Daw_N_C_entity> ns1:Contributor_to <http://example.org/entity/Childrens_Oncology_Group_AREN0321_entity> .

<http://example.org/entity/Dome_J_S_entity> ns1:Published_in <http://example.org/entity/J_Pediatr_Hematol_Oncol_entity> .

<http://example.org/entity/ESRD_entity> ns1:complication <http://example.org/entity/Bilateral_disease_stage_V_entity> .

<http://example.org/entity/Enucleation_entity> ns1:classified_as <http://example.org/entity/NSS_entity> .

<http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_entity> ns1:includes <http://example.org/entity/ExPO_r_Net_entity> .

<http://example.org/entity/Four_drug_regimen_entity> ns1:is_treatment_for <http://example.org/entity/stage_IV_WT_entity> .

<http://example.org/entity/France_entity> ns1:location_of <http://example.org/entity/Armand_Trousseau_Hospital_Paris_entity> .

<http://example.org/entity/Germany_entity> ns1:location_of <http://example.org/entity/University_Hospital_of_Munich_entity> .

<http://example.org/entity/Great_Ormond_Street_Institute_of_Child_Health_entity> ns1:contributed_to <http://example.org/entity/SIOP2001_randomized_trial_entity> .

<http://example.org/entity/Green_D_M_entity> ns1:Published_in <http://example.org/entity/Pediatr_Blood_Cancer_entity> .

<http://example.org/entity/Group_BB_entity> ns1:category_under <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/Group_CC_entity> ns1:category_under <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/Grundy_P_entity> ns1:Published_in <http://example.org/entity/J_Clin_Oncol_entity> .

<http://example.org/entity/HR_entity> ns1:value_for_EFS <http://example.org/entity/238_entity> ;
    ns1:value_for_OS <http://example.org/entity/251_entity> .

<http://example.org/entity/Ha_T_C_entity> ns1:Published_in <http://example.org/entity/Eur_J_Cancer_entity> .

<http://example.org/entity/Hamilton_T_E_entity> ns1:Published_in <http://example.org/entity/Ann_Surg_entity> .

<http://example.org/entity/High_risk_disease_entity> ns1:is_associated_with <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/Indolfi_P_entity> ns1:Published_in <http://example.org/entity/Pediatr_Blood_Cancer_entity> .

<http://example.org/entity/Infant_Wilms_tumours_entity> ns1:treated_with <http://example.org/entity/nephrectomy_entity> .

<http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_entity> ns1:endorses <http://example.org/entity/UMRELLA_SIOP_RTSG_2016_protocol_entity> .

<http://example.org/entity/Intermediate_risk_disease_entity> ns1:is_associated_with <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/International_Society_of_Paediatric_Oncology_Renal_Tumour_Study_Group_SIOPRTSG_entity> ns1:developed <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> .

<http://example.org/entity/Italy_entity> ns1:location_of <http://example.org/entity/Azienda_Ospedaliera_Padova_entity> .

<http://example.org/entity/Kremens_B_entity> ns1:Published_in <http://example.org/entity/Bone_Marrow_Transplant_entity> .

<http://example.org/entity/LogRank_P_entity> ns1:value_for_EFS <http://example.org/entity/001_entity> ;
    ns1:value_for_OS <http://example.org/entity/008_entity> .

<http://example.org/entity/Low_risk_disease_entity> ns1:is_associated_with <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_entity> ns1:contributed_to <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> .

<http://example.org/entity/Metzger_M_L_entity> ns1:Published_in <http://example.org/entity/J_Clin_Oncol_entity> .

<http://example.org/entity/NWTS_5_relapse_protocol_entity> ns1:applies_to <http://example.org/entity/Group_AA_entity> .

<http://example.org/entity/Netherlands_entity> ns1:location_of <http://example.org/entity/Prinses_Maxima_Centrum_Utrecht_entity> .

<http://example.org/entity/Partial_Nephrectomy_entity> ns1:classified_as <http://example.org/entity/NSS_entity> .

<http://example.org/entity/Poland_entity> ns1:location_of <http://example.org/entity/Marciniak_Hospital_Wroclaw_entity> .

<http://example.org/entity/Princess_M%C3%A1xima_Center_for_Paediatric_Oncology_entity> ns1:contributed_to <http://example.org/entity/SIOP2001_randomized_trial_entity> .

<http://example.org/entity/SIOP2001_protocol_entity> ns1:preceded_by <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> .

<http://example.org/entity/SIOP9301_trial_entity> ns1:compared_with <http://example.org/entity/blastemal_type_tumours_entity> .

<http://example.org/entity/SIOPRTSG_entity> ns1:aims_to_improve <http://example.org/entity/Wilms_tumour_treatment_entity> ;
    ns1:collaborated_with <http://example.org/entity/Childrens_Oncology_Group_COG_entity> ;
    ns1:develops_classification_for <http://example.org/entity/NSS_entity> .

<http://example.org/entity/SIOPRTSG_panel_entity> ns1:advises_for <http://example.org/entity/radiotherapy_entity> .

<http://example.org/entity/Segers_H_entity> ns1:Published_in <http://example.org/entity/Expert_Rev_Anticancer_Ther_entity> .

<http://example.org/entity/Spain_entity> ns1:location_of <http://example.org/entity/Hospital_Universitario_Virgin_del_Rocio_Seville_entity> .

<http://example.org/entity/Spreafico_F_entity> ns1:Published_in <http://example.org/entity/Expert_Rev_Anticancer_Ther_entity> .

<http://example.org/entity/Terenziani_M_entity> ns1:Researcher_on <http://example.org/entity/Adult_Wilms_tumor_entity> .

<http://example.org/entity/Tournade_M_F_entity> ns1:Published_in <http://example.org/entity/J_Clin_Oncol_entity> .

<http://example.org/entity/UKW_R_protocol_entity> ns1:applies_to <http://example.org/entity/Group_AA_entity> .

<http://example.org/entity/UK_entity> ns1:location_of <http://example.org/entity/Great_Ormond_Street_Hospital_London_entity> .

<http://example.org/entity/Weirich_A_entity> ns1:Contributor_to <http://example.org/entity/SIOP_9GPOH_entity> .

<http://example.org/entity/Wilms_tumor_entity> ns1:Studied_by <http://example.org/entity/GPOH_entity>,
        <http://example.org/entity/National_Wilms_Tumor_Study_Group_entity>,
        <http://example.org/entity/SIOP_entity> ;
    ns1:Subject_of_study <http://example.org/entity/Childrens_Oncology_Group_study_AREN0533_entity> .

<http://example.org/entity/actinomycin_D_and_vincristine_entity> ns1:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/autologous_stem_cell_rescue_ASCR_entity> ns1:is_treatment_for <http://example.org/entity/stage_IV_WT_entity> .

<http://example.org/entity/blastemal_type_Wilms_tumour_entity> ns1:subtype_of <http://example.org/entity/high_risk_entity> .

<http://example.org/entity/blastemal_type_Wilms_tumours_entity> ns1:investigated_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/camptothecins_irinotecan_or_topotecan_entity> ns1:is_treatment_for <http://example.org/entity/stage_IV_WT_entity> .

<http://example.org/entity/carboplatin_entity> ns1:part_of <http://example.org/entity/HR_1_entity> ;
    ns1:treatment_for <http://example.org/entity/anaplastic_tumours_entity> .

<http://example.org/entity/congenital_mesoblastic_nephroma_entity> ns1:treated_with <http://example.org/entity/nephrectomy_entity> .

<http://example.org/entity/cyclophosphamide_entity> ns1:part_of <http://example.org/entity/HR_1_entity> ;
    ns1:treatment_for <http://example.org/entity/anaplastic_tumours_entity> .

<http://example.org/entity/diffuse_anaplasia_entity> ns1:is_condition_of <http://example.org/entity/Relapsed_group_CC_entity> ;
    ns1:subtype_of <http://example.org/entity/high_risk_entity> .

<http://example.org/entity/epithelial_tumour_types_entity> ns1:associated_with <http://example.org/entity/good_prognosis_entity> .

<http://example.org/entity/etoposide_entity> ns1:part_of <http://example.org/entity/HR_1_entity> ;
    ns1:treatment_for <http://example.org/entity/anaplastic_tumours_entity> .

<http://example.org/entity/event_free_survival_EFS_entity> ns1:compared_with <http://example.org/entity/overall_survival_entity> .

<http://example.org/entity/intermediate_risk_entity> ns1:classification <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/large_volume_tumours_entity> ns1:treated_with <http://example.org/entity/doxorubicin_entity> .

<http://example.org/entity/low_risk_entity> ns1:classification <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/lung_or_metastasis_radiotherapy_entity> ns1:is_treatment_for <http://example.org/entity/stage_IV_WT_entity> .

<http://example.org/entity/malignant_rhabdoid_tumours_entity> ns1:treated_with_alternative <http://example.org/entity/chemotherapy_entity> .

<http://example.org/entity/metastatic_disease_entity> ns1:equivalent_to <http://example.org/entity/stage_IV_disease_entity> .

<http://example.org/entity/proton_therapy_entity> ns1:potential_for <http://example.org/entity/flank_irradiation_entity> .

<http://example.org/entity/pulmonary_metastases_entity> ns1:detected_by <http://example.org/entity/chest_CT_entity> .

<http://example.org/entity/pulmonary_radiotherapy_entity> ns1:is_treatment_for <http://example.org/entity/stage_IV_WT_entity> .

<http://example.org/entity/stromal_tumour_types_entity> ns1:associated_with <http://example.org/entity/good_prognosis_entity> .

<http://example.org/entity/van_den_Heuvel_Eibrink_M_M_entity> ns1:Published_in <http://example.org/entity/Pediatr_Blood_Cancer_entity> .

<http://example.org/entity/vincristine_entity> ns1:combined_with <http://example.org/entity/actinomycin_D_entity> ;
    ns1:treatment_for <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/whole_lung_irradiation_entity> ns1:combined_with <http://example.org/entity/doxorubicin_actinomycin_D_vincristine_entity> .

<http://example.org/entity/001_Value_for_EFS> a ns2:Value_for_EFS ;
    ns2:name "0.01" .

<http://example.org/entity/008_Value_for_OS> a ns2:Value_for_OS ;
    ns2:name "0.08" .

<http://example.org/entity/238_Statistic_for_EFS> a ns2:Statistic_for_EFS ;
    ns2:name "2.38" .

<http://example.org/entity/251_Statistic_for_OS> a ns2:Statistic_for_OS ;
    ns2:name "2.51" .

<http://example.org/entity/60_month_EFS_500_ml_Data> a ns2:Data ;
    ns2:name "60-month EFS – 500+ ml",
        "60-month EFS – <500 ml" .

<http://example.org/entity/60_month_EFS_AVD_500_ml_data_point> a ns2:data_point ;
    ns2:name "60-month EFS - AVD. 500+ ml",
        "60-month EFS - AVD. <500 ml" .

<http://example.org/entity/60_month_EFS_AV_2_500_ml_data_point> a ns2:data_point ;
    ns2:name "60-month EFS - AV-2. 500+ ml",
        "60-month EFS - AV-2. <500 ml" .

<http://example.org/entity/60_month_OS_500_ml_Data> a ns2:Data ;
    ns2:name "60-month OS – 500+ ml",
        "60-month OS – <500 ml" .

<http://example.org/entity/60_month_OS_AVD_500_ml_data_point> a ns2:data_point ;
    ns2:name "60-month OS - AVD. 500+ ml",
        "60-month OS - AVD. <500 ml" .

<http://example.org/entity/60_month_OS_AV_2_500_ml_data_point> a ns2:data_point ;
    ns2:name "60-month OS - AV-2. 500+ ml",
        "60-month OS - AV-2. <500 ml" .

<http://example.org/entity/800_Statistic> a ns2:Statistic ;
    ns2:name "80.0" .

<http://example.org/entity/800_entity> ns1:has_confidence_interval <http://example.org/entity/95_Cl_705_908_entity> .

<http://example.org/entity/903_Statistic> a ns2:Statistic ;
    ns2:name "90.3" .

<http://example.org/entity/903_entity> ns1:has_confidence_interval <http://example.org/entity/95_Cl_871_935_entity> .

<http://example.org/entity/931_Statistic> a ns2:Statistic ;
    ns2:name "93.1" .

<http://example.org/entity/931_entity> ns1:has_confidence_interval <http://example.org/entity/95_Cl_868_999_entity> .

<http://example.org/entity/95_Cl_705_908_Confidence_Interval> a ns2:Confidence_Interval ;
    ns2:name "95% Cl: 70.5 – 90.8" .

<http://example.org/entity/95_Cl_868_999_Confidence_Interval> a ns2:Confidence_Interval ;
    ns2:name "95% Cl: 86.8 – 99.9" .

<http://example.org/entity/95_Cl_871_935_Confidence_Interval> a ns2:Confidence_Interval ;
    ns2:name "95% Cl: 87.1 – 93.5" .

<http://example.org/entity/95_Cl_946_988_Confidence_Interval> a ns2:Confidence_Interval ;
    ns2:name "95% Cl: 94.6 – 98.8" .

<http://example.org/entity/967_Statistic> a ns2:Statistic ;
    ns2:name "96.7" .

<http://example.org/entity/967_entity> ns1:has_confidence_interval <http://example.org/entity/95_Cl_946_988_entity> .

<http://example.org/entity/AREN0533_Study> a ns2:Study ;
    ns2:name "AREN0533" .

<http://example.org/entity/AVD150_treatment> a ns2:treatment ;
    ns2:name "AVD150" .

<http://example.org/entity/AVD250_treatment> a ns2:treatment ;
    ns2:name "AVD250" .

<http://example.org/entity/Adult_Wilms_tumor_Condition> a ns2:Condition ;
    ns2:name "Adult Wilms’ tumor" .

<http://example.org/entity/Ann_Surg_Journal> a ns2:Journal ;
    ns2:name "Ann. Surg." .

<http://example.org/entity/Anne_M_Smets_author> a ns2:author ;
    ns2:name "Anne M. Smets" .

<http://example.org/entity/Arnauld_C_Verschuur_author> a ns2:author ;
    ns2:name "Arnauld C. Verschuur" .

<http://example.org/entity/Aronson_D_C_Author> a ns2:Author ;
    ns2:name "Aronson, D. C." .

<http://example.org/entity/Austria_Country> a ns2:Country ;
    ns2:name "Austria" .

<http://example.org/entity/Beatriz_de_Camargo_author> a ns2:author ;
    ns2:name "Beatriz de Camargo" .

<http://example.org/entity/Bilateral_disease_stage_V_condition_stage> a ns2:condition_stage ;
    ns2:name "Bilateral disease (stage V)" .

<http://example.org/entity/Bilateral_disease_stage_V_entity> ns1:instance_of <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/Bone_Marrow_Transplant_Journal> a ns2:Journal ;
    ns2:name "Bone Marrow Transplant." .

<http://example.org/entity/Breslow_N_E_Author> a ns2:Author ;
    ns2:name "Breslow, N. E." .

<http://example.org/entity/Brok_J_Author> a ns2:Author ;
    ns2:name "Brok, J." .

<http://example.org/entity/CCSK_medical_condition> a ns2:medical_condition ;
    ns2:name "CCSK" .

<http://example.org/entity/CDCV_treatment> a ns2:treatment ;
    ns2:name "CDCV" .

<http://example.org/entity/CMN_medical_condition> a ns2:medical_condition ;
    ns2:name "CMN" .

<http://example.org/entity/COGNWTS_study> a ns2:study ;
    ns2:name "COG–NWTS" .

<http://example.org/entity/COG_protocol_Protocol> a ns2:Protocol ;
    ns2:name "COG protocol" .

<http://example.org/entity/CT_diagnostic_procedure> a ns2:diagnostic_procedure ;
    ns2:name "CT" .

<http://example.org/entity/CT_only_nodules_Medical_Term> a ns2:Medical_Term ;
    ns2:name "CT-only nodules" .

<http://example.org/entity/Childrens_Oncology_Group_AREN0321_Study> a ns2:Study ;
    ns2:name "Children’s Oncology Group AREN0321" .

<http://example.org/entity/Childrens_Oncology_Group_COG_organization> a ns2:organization ;
    ns2:name "Children’s Oncology Group (COG)" .

<http://example.org/entity/Childrens_Oncology_Group_study_AREN0533_Study> a ns2:Study ;
    ns2:name "Children’s Oncology Group study AREN0533" .

<http://example.org/entity/Christian_R%C3%BCbe_author> a ns2:author ;
    ns2:name "Christian Rübe" .

<http://example.org/entity/Christophe_Bergeron_author> a ns2:author ;
    ns2:name "Christophe Bergeron" .

<http://example.org/entity/Davila_Fajardo_author> a ns2:author ;
    ns2:name "Davila Fajardo" .

<http://example.org/entity/Daw_N_C_Author> a ns2:Author ;
    ns2:name "Daw, N. C." .

<http://example.org/entity/Dome_J_S_Author> a ns2:Author ;
    ns2:name "Dome, J. S." .

<http://example.org/entity/ESRD_condition> a ns2:condition ;
    ns2:name "ESRD" .

<http://example.org/entity/Enucleation_Surgical_Technique> a ns2:Surgical_Technique ;
    ns2:name "Enucleation" .

<http://example.org/entity/Eur_J_Cancer_Journal> a ns2:Journal ;
    ns2:name "Eur. J. Cancer" .

<http://example.org/entity/Europe_Region> a ns2:Region ;
    ns2:name "Europe" .

<http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_Project> a ns2:Project ;
    ns2:name "European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment" .

<http://example.org/entity/ExPO_r_Net_Platform> a ns2:Platform ;
    ns2:name "ExPO-r-Net" .

<http://example.org/entity/Expert_Rev_Anticancer_Ther_Journal> a ns2:Journal ;
    ns2:name "Expert Rev. Anticancer Ther." .

<http://example.org/entity/Filippo_Spreafico_author> a ns2:author ;
    ns2:name "Filippo Spreafico" .

<http://example.org/entity/Four_drug_regimen_treatment> a ns2:treatment ;
    ns2:name "Four-drug regimen" .

<http://example.org/entity/France_Country> a ns2:Country ;
    ns2:name "France" .

<http://example.org/entity/Furtwangler_R_Author> a ns2:Author ;
    ns2:name "Furtwangler, R." .

<http://example.org/entity/GPOH_Organization> a ns2:Organization ;
    ns2:name "GPOH" .

<http://example.org/entity/Geert_O_Janssens_author> a ns2:author ;
    ns2:name "Geert O. Janssens" .

<http://example.org/entity/Gema_L_Ram%C3%ADrez_Villar_author> a ns2:author ;
    ns2:name "Gema L. Ramírez-Villar" .

<http://example.org/entity/Germany_Country> a ns2:Country ;
    ns2:name "Germany" .

<http://example.org/entity/Gordan_M_Vujanic_author> a ns2:author ;
    ns2:name "Gordan M. Vujanic" .

<http://example.org/entity/Great_Ormond_Street_Institute_of_Child_Health_institution> a ns2:institution ;
    ns2:name "Great Ormond Street Institute of Child Health" .

<http://example.org/entity/Green_D_M_Author> a ns2:Author ;
    ns2:name "Green, D. M." .

<http://example.org/entity/Group_AA_patient_group> a ns2:patient_group ;
    ns2:name "Group AA" .

<http://example.org/entity/Group_BB_patient_group> a ns2:patient_group ;
    ns2:name "Group BB" .

<http://example.org/entity/Group_CC_patient_group> a ns2:patient_group ;
    ns2:name "Group CC" .

<http://example.org/entity/Grundy_P_Author> a ns2:Author ;
    ns2:name "Grundy, P." .

<http://example.org/entity/HR_1_treatment_regimen> a ns2:treatment_regimen ;
    ns2:name "HR-1" .

<http://example.org/entity/HR_Metric> a ns2:Metric ;
    ns2:name "HR" .

<http://example.org/entity/Ha_T_C_Author> a ns2:Author ;
    ns2:name "Ha, T. C." .

<http://example.org/entity/Hale_J_Author> a ns2:Author ;
    ns2:name "Hale, J." .

<http://example.org/entity/Hamilton_T_E_Author> a ns2:Author ;
    ns2:name "Hamilton, T. E." .

<http://example.org/entity/Harm_van_Tinteren_author> a ns2:author ;
    ns2:name "Harm van Tinteren" .

<http://example.org/entity/Heidi_Segers_author> a ns2:author ;
    ns2:name "Heidi Segers" .

<http://example.org/entity/High_risk_disease_risk_category> a ns2:risk_category ;
    ns2:name "High-risk disease" .

<http://example.org/entity/Hospital_Universitario_Virgen_del_Roc%C3%ADo_institution> a ns2:institution ;
    ns2:name "Hospital Universitario Virgen del Rocío" .

<http://example.org/entity/Iceland_Country> a ns2:Country ;
    ns2:name "Iceland" .

<http://example.org/entity/Indolfi_P_Author> a ns2:Author ;
    ns2:name "Indolfi, P." .

<http://example.org/entity/Infant_Wilms_tumours_Disease> a ns2:Disease ;
    ns2:name "Infant Wilms tumours" .

<http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_organization> a ns2:organization ;
    ns2:name "Innovative Therapies for Children with Cancer consortium" .

<http://example.org/entity/Instituto_Nacional_de_Cancer_INCA_institution> a ns2:institution ;
    ns2:name "Instituto Nacional de Cancer (INCA)" .

<http://example.org/entity/Intermediate_risk_disease_risk_category> a ns2:risk_category ;
    ns2:name "Intermediate-risk disease" .

<http://example.org/entity/International_Society_of_Paediatric_Oncology_Renal_Tumour_Study_Group_SIOPRTSG_organization> a ns2:organization ;
    ns2:name "International Society of Paediatric Oncology — Renal Tumour Study Group (SIOP–RTSG)" .

<http://example.org/entity/International_collaboration_Concept> a ns2:Concept ;
    ns2:name "International collaboration" .

<http://example.org/entity/Italy_Country> a ns2:Country ;
    ns2:name "Italy" .

<http://example.org/entity/Ivo_Leuschner_author> a ns2:author ;
    ns2:name "Ivo Leuschner" .

<http://example.org/entity/J_Clin_Oncol_Journal> a ns2:Journal ;
    ns2:name "J. Clin. Oncol." .

<http://example.org/entity/J_Pediatr_Hematol_Oncol_Journal> a ns2:Journal ;
    ns2:name "J. Pediatr. Hematol. Oncol." .

<http://example.org/entity/J_Urol_Journal> a ns2:Journal ;
    ns2:name "J. Urol." .

<http://example.org/entity/Jan_Godzinski_author> a ns2:author ;
    ns2:name "Jan Godzinski" .

<http://example.org/entity/Janna_A_Hol_author> a ns2:author ;
    ns2:name "Janna A. Hol" .

<http://example.org/entity/Jesper_Brok_author> a ns2:author ;
    ns2:name "Jesper Brok" .

<http://example.org/entity/Kaplan_Meier_analysis_analysis_method> a ns2:analysis_method ;
    ns2:name "Kaplan Meier analysis" .

<http://example.org/entity/Kathy_Pritchard_Jones_author> a ns2:author ;
    ns2:name "Kathy Pritchard-Jones" .

<http://example.org/entity/Klin_Padiatr_Journal> a ns2:Journal ;
    ns2:name "Klin. Padiatr." .

<http://example.org/entity/Kremens_B_Author> a ns2:Author ;
    ns2:name "Kremens, B." .

<http://example.org/entity/LogRank_P_Statistic_Type> a ns2:Statistic_Type ;
    ns2:name "Log–Rank P" .

<http://example.org/entity/Low_risk_disease_risk_category> a ns2:risk_category ;
    ns2:name "Low-risk disease" .

<http://example.org/entity/MRTK_medical_condition> a ns2:medical_condition ;
    ns2:name "MRTK" .

<http://example.org/entity/Manfred_Gessler_author> a ns2:author ;
    ns2:name "Manfred Gessler" .

<http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_author> a ns2:author ;
    ns2:name "Marry M. van den Heuvel-Eibrink" .

<http://example.org/entity/Metzger_M_L_Journal_Author> a ns2:Journal_Author ;
    ns2:name "Metzger, M. L." .

<http://example.org/entity/NSS_Surgical_Technique> a ns2:Surgical_Technique ;
    ns2:name "NSS" .

<http://example.org/entity/NSS_surgery_type> a ns2:surgery_type ;
    ns2:name "NSS" .

<http://example.org/entity/NWTS_4_Study> a ns2:Study ;
    ns2:name "NWTS-4" .

<http://example.org/entity/NWTS_5_Study> a ns2:Study ;
    ns2:name "NWTS-5" .

<http://example.org/entity/NWTS_5_relapse_protocol_study> a ns2:study ;
    ns2:name "NWTS-5 relapse protocol" .

<http://example.org/entity/National_Wilms_Tumor_Study_Group_Organization> a ns2:Organization ;
    ns2:name "National Wilms Tumor Study Group" .

<http://example.org/entity/Netherlands_Cancer_Institute_institution> a ns2:institution ;
    ns2:name "Netherlands Cancer Institute" .

<http://example.org/entity/Netherlands_Country> a ns2:Country ;
    ns2:name "Netherlands" .

<http://example.org/entity/Norbert_Graf_author> a ns2:author ;
    ns2:name "Norbert Graf" .

<http://example.org/entity/Paola_Collini_author> a ns2:author ;
    ns2:name "Paola Collini" .

<http://example.org/entity/Partial_Nephrectomy_Surgical_Technique> a ns2:Surgical_Technique ;
    ns2:name "Partial Nephrectomy" .

<http://example.org/entity/Pediatr_Blood_Cancer_Journal> a ns2:Journal ;
    ns2:name "Pediatr. Blood Cancer" .

<http://example.org/entity/Poland_Country> a ns2:Country ;
    ns2:name "Poland" .

<http://example.org/entity/Princess_M%C3%A1xima_Center_for_Paediatric_Oncology_institution> a ns2:institution ;
    ns2:name "Princess Máxima Center for Paediatric Oncology" .

<http://example.org/entity/RCC_medical_condition> a ns2:medical_condition ;
    ns2:name "RCC" .

<http://example.org/entity/Relapsed_group_CC_patient_group> a ns2:patient_group ;
    ns2:name "Relapsed group CC" .

<http://example.org/entity/Rhoikos_Furtw%C3%A4ngler_author> a ns2:author ;
    ns2:name "Rhoikos Furtwängler" .

<http://example.org/entity/SIOP2001_Study> a ns2:Study ;
    ns2:name "SIOP−2001" .

<http://example.org/entity/SIOP2001_entity> ns1:refines <http://example.org/entity/radiotherapy_entity> ;
    ns1:study_of <http://example.org/entity/Wilms_tumour_entity> ;
    ns1:treatment_in_study <http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_entity> .

<http://example.org/entity/SIOP2001_protocol_protocol> a ns2:protocol ;
    ns2:name "SIOP−2001 protocol" .

<http://example.org/entity/SIOP2001_randomized_trial_clinical_trial> a ns2:clinical_trial ;
    ns2:name "SIOP−2001 randomized trial" .

<http://example.org/entity/SIOP2001_study> a ns2:study ;
    ns2:name "SIOP−2001" .

<http://example.org/entity/SIOP9301_trial_trial> a ns2:trial ;
    ns2:name "SIOP−93–01 trial" .

<http://example.org/entity/SIOPRTSG_Organization> a ns2:Organization ;
    ns2:name "SIOP–RTSG" .

<http://example.org/entity/SIOPRTSG_organization> a ns2:organization ;
    ns2:name "SIOP–RTSG" .

<http://example.org/entity/SIOPRTSG_panel_Organization> a ns2:Organization ;
    ns2:name "SIOP−RTSG panel" .

<http://example.org/entity/SIOP_2001_trial_trial> a ns2:trial ;
    ns2:name "SIOP-2001 trial" .

<http://example.org/entity/SIOP_9GPOH_Trial> a ns2:Trial ;
    ns2:name "SIOP-9/GPOH" .

<http://example.org/entity/SIOP_Organization> a ns2:Organization ;
    ns2:name "SIOP" .

<http://example.org/entity/SIOP_renal_tumour_protocol_Protocol> a ns2:Protocol ;
    ns2:name "SIOP renal tumour protocol" .

<http://example.org/entity/Segers_H_Author> a ns2:Author ;
    ns2:name "Segers, H." .

<http://example.org/entity/Spain_Country> a ns2:Country ;
    ns2:name "Spain" .

<http://example.org/entity/Spreafico_F_Author> a ns2:Author ;
    ns2:name "Spreafico, F." .

<http://example.org/entity/Sudour_H_Author> a ns2:Author ;
    ns2:name "Sudour, H." .

<http://example.org/entity/Terenziani_M_Author> a ns2:Author ;
    ns2:name "Terenziani, M." .

<http://example.org/entity/Tournade_M_F_Author> a ns2:Author ;
    ns2:name "Tournade, M. F." .

<http://example.org/entity/UKW3_trial_clinical_trial> a ns2:clinical_trial ;
    ns2:name "UKW3 trial" .

<http://example.org/entity/UKW_R_protocol_study> a ns2:study ;
    ns2:name "UKW-R protocol" .

<http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_organization> a ns2:organization ;
    ns2:name "UK Children’s Cancer and Leukaemia Group (UKCCLG)" .

<http://example.org/entity/UK_Country> a ns2:Country ;
    ns2:name "UK" .

<http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_protocol> a ns2:protocol ;
    ns2:name "UMBRELLA SIOP–RTSG 2016 protocol" .

<http://example.org/entity/UMBRELLA_protocol_Project> a ns2:Project ;
    ns2:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_Protocol> a ns2:Protocol ;
    ns2:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_guideline> a ns2:guideline ;
    ns2:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_protocol> a ns2:protocol ;
    ns2:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_treatment_protocol> a ns2:treatment_protocol ;
    ns2:name "UMBRELLA protocol" .

<http://example.org/entity/UMRELLA_SIOP_RTSG_2016_protocol_entity> ns1:is_protocol_for <http://example.org/entity/stage_IV_WT_entity> .

<http://example.org/entity/UMRELLA_SIOP_RTSG_2016_protocol_protocol> a ns2:protocol ;
    ns2:name "UMRELLA-SIOP-RTSG-2016 protocol" .

<http://example.org/entity/University_Hospital_of_Wales_institution> a ns2:institution ;
    ns2:name "University Hospital of Wales" .

<http://example.org/entity/Weirich_A_Author> a ns2:Author ;
    ns2:name "Weirich, A." .

<http://example.org/entity/Wilms_tumor_Condition> a ns2:Condition ;
    ns2:name "Wilms' tumor" .

<http://example.org/entity/Wilms_tumour_Disease> a ns2:Disease ;
    ns2:name "Wilms tumour" .

<http://example.org/entity/Wilms_tumour_cancer_type> a ns2:cancer_type ;
    ns2:name "Wilms tumour" .

<http://example.org/entity/Wilms_tumour_condition> a ns2:condition ;
    ns2:name "Wilms tumour" .

<http://example.org/entity/Wilms_tumour_disease> a ns2:disease ;
    ns2:name "Wilms tumour" .

<http://example.org/entity/Wilms_tumour_medical_condition> a ns2:medical_condition ;
    ns2:name "Wilms tumour" .

<http://example.org/entity/Wilms_tumour_treatment_Medical_treatment> a ns2:Medical_treatment ;
    ns2:name "Wilms tumour treatment" .

<http://example.org/entity/Wilms_tumours_disease> a ns2:disease ;
    ns2:name "Wilms tumours" .

<http://example.org/entity/Wilms_tumours_medical_condition> a ns2:medical_condition ;
    ns2:name "Wilms tumours" .

<http://example.org/entity/actinomycin_D_Medication> a ns2:Medication ;
    ns2:name "actinomycin D" .

<http://example.org/entity/actinomycin_D_drug> a ns2:drug ;
    ns2:name "actinomycin D",
        "actinomycin-D" .

<http://example.org/entity/actinomycin_D_entity> ns1:treatment_for <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/adult_patients_Patient_Group> a ns2:Patient_Group ;
    ns2:name "adult patients" .

<http://example.org/entity/autologous_stem_cell_rescue_ASCR_treatment> a ns2:treatment ;
    ns2:name "autologous stem cell rescue (ASCR)" .

<http://example.org/entity/blastemal_type_Wilms_tumour_medical_condition> a ns2:medical_condition ;
    ns2:name "blastemal-type Wilms tumour" .

<http://example.org/entity/blastemal_type_Wilms_tumours_subtype> a ns2:subtype ;
    ns2:name "blastemal-type Wilms tumours" .

<http://example.org/entity/blastemal_type_tumours_disease_attribute> a ns2:disease_attribute ;
    ns2:name "blastemal-type tumours" .

<http://example.org/entity/blastemal_type_tumours_entity> ns1:is_condition_of <http://example.org/entity/Relapsed_group_CC_entity> ;
    ns1:treated_with <http://example.org/entity/doxorubicin_entity> .

<http://example.org/entity/blastemal_type_tumours_medical_condition> a ns2:medical_condition ;
    ns2:name "blastemal-type tumours" .

<http://example.org/entity/camptothecins_irinotecan_or_topotecan_medical_substance> a ns2:medical_substance ;
    ns2:name "camptothecins (irinotecan or topotecan)" .

<http://example.org/entity/carboplatin_Medication> a ns2:Medication ;
    ns2:name "carboplatin" .

<http://example.org/entity/carboplatin_drug> a ns2:drug ;
    ns2:name "carboplatin" .

<http://example.org/entity/carboplatin_medical_substance> a ns2:medical_substance ;
    ns2:name "carboplatin" .

<http://example.org/entity/chemotherapy_Treatment> a ns2:Treatment ;
    ns2:name "chemotherapy" .

<http://example.org/entity/chemotherapy_entity> ns1:follows_after <http://example.org/entity/nephrectomy_entity> ;
    ns1:treatment_for <http://example.org/entity/Wilms_tumour_entity> ;
    ns1:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/chemotherapy_treatment> a ns2:treatment ;
    ns2:name "chemotherapy" .

<http://example.org/entity/chest_CT_diagnostic_tool> a ns2:diagnostic_tool ;
    ns2:name "chest CT" .

<http://example.org/entity/childhood_renal_tumours_disease> a ns2:disease ;
    ns2:name "childhood renal tumours" .

<http://example.org/entity/clear_cell_sarcoma_of_the_kidney_disease> a ns2:disease ;
    ns2:name "clear cell sarcoma of the kidney" .

<http://example.org/entity/congenital_mesoblastic_nephroma_Disease> a ns2:Disease ;
    ns2:name "congenital mesoblastic nephroma" .

<http://example.org/entity/congenital_mesoblastic_nephroma_disease> a ns2:disease ;
    ns2:name "congenital mesoblastic nephroma" .

<http://example.org/entity/cumulative_doxorubicin_dose_of_300_mgm2_Dosage> a ns2:Dosage ;
    ns2:name "cumulative doxorubicin dose of 300 mg/m2" .

<http://example.org/entity/cyclophosphamide_Medication> a ns2:Medication ;
    ns2:name "cyclophosphamide" .

<http://example.org/entity/cyclophosphamide_drug> a ns2:drug ;
    ns2:name "cyclophosphamide" .

<http://example.org/entity/cyclophosphamide_medical_substance> a ns2:medical_substance ;
    ns2:name "cyclophosphamide" .

<http://example.org/entity/diffuse_anaplasia_disease_attribute> a ns2:disease_attribute ;
    ns2:name "diffuse anaplasia" .

<http://example.org/entity/diffuse_anaplasia_medical_condition> a ns2:medical_condition ;
    ns2:name "diffuse anaplasia" .

<http://example.org/entity/dose_of_150_mgm2_Dosage> a ns2:Dosage ;
    ns2:name "dose of 150 mg/m2" .

<http://example.org/entity/doxorubicin_Medication> a ns2:Medication ;
    ns2:name "doxorubicin" .

<http://example.org/entity/doxorubicin_drug> a ns2:drug ;
    ns2:name "doxorubicin" .

<http://example.org/entity/epithelial_tumour_types_medical_condition> a ns2:medical_condition ;
    ns2:name "epithelial tumour types" .

<http://example.org/entity/etoposide_Medication> a ns2:Medication ;
    ns2:name "etoposide" .

<http://example.org/entity/etoposide_drug> a ns2:drug ;
    ns2:name "etoposide" .

<http://example.org/entity/etoposide_medical_substance> a ns2:medical_substance ;
    ns2:name "etoposide" .

<http://example.org/entity/event_free_survival_EFS_outcome_measure> a ns2:outcome_measure ;
    ns2:name "event-free survival (EFS)" .

<http://example.org/entity/flank_irradiation_treatment> a ns2:treatment ;
    ns2:name "flank irradiation" .

<http://example.org/entity/focal_anaplasia_type_tumours_medical_condition> a ns2:medical_condition ;
    ns2:name "focal anaplasia-type tumours" .

<http://example.org/entity/high_risk_risk_level> a ns2:risk_level ;
    ns2:name "high-risk" .

<http://example.org/entity/ifosfamide_medical_substance> a ns2:medical_substance ;
    ns2:name "ifosfamide" .

<http://example.org/entity/intermediate_risk_risk_level> a ns2:risk_level ;
    ns2:name "intermediate-risk" .

<http://example.org/entity/large_volume_tumours_medical_condition> a ns2:medical_condition ;
    ns2:name "large-volume tumours" .

<http://example.org/entity/low_risk_risk_level> a ns2:risk_level ;
    ns2:name "low-risk" .

<http://example.org/entity/lung_or_metastasis_radiotherapy_treatment> a ns2:treatment ;
    ns2:name "lung or metastasis radiotherapy" .

<http://example.org/entity/malignant_rhabdoid_tumour_of_the_kidney_disease> a ns2:disease ;
    ns2:name "malignant rhabdoid tumour of the kidney" .

<http://example.org/entity/malignant_rhabdoid_tumours_Disease> a ns2:Disease ;
    ns2:name "malignant rhabdoid tumours" .

<http://example.org/entity/metastatic_disease_medical_condition> a ns2:medical_condition ;
    ns2:name "metastatic disease" .

<http://example.org/entity/minimally_invasive_or_laparoscopic_surgery_entity> ns1:addressed_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/minimally_invasive_or_laparoscopic_surgery_surgery_type> a ns2:surgery_type ;
    ns2:name "minimally invasive or laparoscopic surgery" .

<http://example.org/entity/mixed_tumours_medical_condition> a ns2:medical_condition ;
    ns2:name "mixed tumours" .

<http://example.org/entity/nephrectomy_Treatment> a ns2:Treatment ;
    ns2:name "nephrectomy" .

<http://example.org/entity/non_Wilms_tumours_disease_category> a ns2:disease_category ;
    ns2:name "non-Wilms tumours" .

<http://example.org/entity/overall_survival_outcome_measure> a ns2:outcome_measure ;
    ns2:name "overall survival" .

<http://example.org/entity/proton_therapy_treatment> a ns2:treatment ;
    ns2:name "proton therapy" .

<http://example.org/entity/pulmonary_metastases_medical_condition> a ns2:medical_condition ;
    ns2:name "pulmonary metastases" .

<http://example.org/entity/pulmonary_radiotherapy_treatment> a ns2:treatment ;
    ns2:name "pulmonary radiotherapy" .

<http://example.org/entity/radiotherapy_Treatment> a ns2:Treatment ;
    ns2:name "radiotherapy" .

<http://example.org/entity/radiotherapy_treatment> a ns2:treatment ;
    ns2:name "radiotherapy" .

<http://example.org/entity/renal_cell_carcinoma_disease> a ns2:disease ;
    ns2:name "renal cell carcinoma" .

<http://example.org/entity/renal_tumour_patients_population> a ns2:population ;
    ns2:name "renal tumour patients" .

<http://example.org/entity/stage_IIIII_regressive_tumours_medical_condition> a ns2:medical_condition ;
    ns2:name "stage II–III regressive tumours" .

<http://example.org/entity/stage_IV_WT_cancer_stage> a ns2:cancer_stage ;
    ns2:name "stage IV WT" .

<http://example.org/entity/stage_IV_disease_medical_condition> a ns2:medical_condition ;
    ns2:name "stage IV disease" .

<http://example.org/entity/stromal_tumour_types_medical_condition> a ns2:medical_condition ;
    ns2:name "stromal tumour types" .

<http://example.org/entity/surgery_Treatment> a ns2:Treatment ;
    ns2:name "surgery" .

<http://example.org/entity/surgery_entity> ns1:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/surgery_treatment> a ns2:treatment ;
    ns2:name "surgery" .

<http://example.org/entity/van_den_Heuvel_Eibrink_M_M_Author> a ns2:Author ;
    ns2:name "van den Heuvel-Eibrink, M. M." .

<http://example.org/entity/vincristine_Medication> a ns2:Medication ;
    ns2:name "vincristine" .

<http://example.org/entity/vincristine_and_actinomycin_D_Treatment> a ns2:Treatment ;
    ns2:name "vincristine and actinomycin D" .

<http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_Treatment> a ns2:Treatment ;
    ns2:name "vincristine and actinomycin D plus doxorubicin" .

<http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_entity> ns1:has_dosage <http://example.org/entity/cumulative_doxorubicin_dose_of_300_mgm2_entity> .

<http://example.org/entity/vincristine_and_irinotecan_Treatment> a ns2:Treatment ;
    ns2:name "vincristine and irinotecan" .

<http://example.org/entity/vincristine_drug> a ns2:drug ;
    ns2:name "vincristine" .

<http://example.org/entity/whole_lung_irradiation_treatment> a ns2:treatment ;
    ns2:name "whole-lung irradiation" .

<http://example.org/entity/wwwsiop_rtsgeu_website> a ns2:website ;
    ns2:name "www.siop-rtsg.eu" .

<http://example.org/entity/Group_AA_entity> ns1:category_under <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/doxorubicin_entity> ns1:part_of <http://example.org/entity/HR_1_entity>,
        <http://example.org/entity/SIOP_2001_trial_entity> ;
    ns1:treatment_for <http://example.org/entity/adult_patients_entity> ;
    ns1:used_for <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/high_risk_entity> ns1:classification <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/NSS_entity> ns1:alternative_to <http://example.org/entity/minimally_invasive_or_laparoscopic_surgery_entity> ;
    ns1:technique_for <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> ns1:addresses <http://example.org/entity/Wilms_tumour_entity>,
        <http://example.org/entity/childhood_renal_tumours_entity>,
        <http://example.org/entity/non_Wilms_tumours_entity> .

<http://example.org/entity/radiotherapy_entity> ns1:sometimes_used_for <http://example.org/entity/Wilms_tumours_entity> ;
    ns1:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/UMBRELLA_protocol_entity> ns1:adapts <http://example.org/entity/SIOP2001_trial_entity> ;
    ns1:application <http://example.org/entity/Wilms_tumour_entity> ;
    ns1:guides <http://example.org/entity/International_collaboration_entity> ;
    ns1:includes_definition <http://example.org/entity/CT_only_nodules_entity> ;
    ns1:provides_guidelines_for <http://example.org/entity/radiotherapy_entity>,
        <http://example.org/entity/surgery_entity> ;
    ns1:utilized_in <http://example.org/entity/Europe_entity> .

<http://example.org/entity/Wilms_tumours_entity> ns1:is_focus_of <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/stage_IV_WT_entity> ns1:is_stage_of <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/Wilms_tumour_entity> ns1:diagnosed_in <http://example.org/entity/adult_patients_entity> ;
    ns1:differentiates_from <http://example.org/entity/CCSK_entity>,
        <http://example.org/entity/CMN_entity>,
        <http://example.org/entity/MRTK_entity>,
        <http://example.org/entity/RCC_entity> .

